-+ 0.00%
-+ 0.00%
-+ 0.00%

Summit Therapeutics Plans To Offer $380M Common Shares

Benzinga·07/23/2026 20:39:16
语音播报

https://www.sec.gov/ix?doc=/Archives/edgar/data/1599298/000119312526314214/d143170d8k.htm